Correlation Between Tscan Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Tscan Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Tscan Therapeutics and Milestone Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tscan and Milestone is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Milestone Pharmaceuticals. In addition to that, Tscan Therapeutics is 1.39 times more volatile than Milestone Pharmaceuticals. It trades about -0.11 of its total potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.1 per unit of volatility. If you would invest 148.00 in Milestone Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 51.00 from holding Milestone Pharmaceuticals or generate 34.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Tscan Therapeutics |
| Milestone Pharmaceuticals |
Tscan Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Tscan Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Tscan Therapeutics vs. DiaMedica Therapeutics | Tscan Therapeutics vs. Lyra Therapeutics | Tscan Therapeutics vs. Centessa Pharmaceuticals PLC |
| Milestone Pharmaceuticals vs. DiaMedica Therapeutics | Milestone Pharmaceuticals vs. Lyra Therapeutics | Milestone Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |